Inventor · disambiguated record
Yoshiharu Mizui
Also filed as: MIZUI YOSHIHARU
8 granted patents·4 pending applications·92 citations·filing 1993–2020
87Inventor score
Top patents by PatentIndex Score
12 records- 0186US7026352B1Physiologically active substancesEISAI CO LTD·Filed 2002·Granted Apr 11, 2006·32 cites·92 claims
- 0284US8329742B2Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2010·Granted Dec 11, 2012·9 cites·32 claims
- 0382US10889866B2Splice variants associated with neomorphic SF3B1 mutantsEISAI R&D MAN CO LTD·Filed 2016·Granted Jan 12, 2021·2 cites·18 claims
- 0482US7799827B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Sep 21, 2010·16 cites·30 claims
- 0582US7667052B2Bioactive substanceEISAI R&D MAN CO LTD·Filed 2005·Granted Feb 23, 2010·7 cites·29 claims
- 0677US7915306B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Mar 29, 2011·13 cites·92 claims
- 0763US11761045B2Splice variants associated with neomorphic SF3B1 mutantsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 19, 2023·0 cites·25 claims
- 0857US5420252AHuman antithrombin III mutantsEISAI CO LTD·Filed 1993·Granted May 30, 1995·13 cites·16 claims
- 0951US2013196987A1Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2012·Application pending·0 cites
- 1047US2010086931A1Method for assaying action of antitumor agent using decrease in gene expression level as indexEISAI R&D MAN CO LTD·Filed 2008·Application pending·0 cites
- 1147US2010021918A1Method for assaying action of antitumor agent using splicing defects as indexEISAI R&D MAN CO LTD·Filed 2008·Application pending·0 cites
- 1247US2009227795A1Target molecules of pladienolides, compounds binding to such target molecules, and screening method thereofEISAI R&D MAN CO LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yoshiharu Mizui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →